Trial Profile
An Open-label, Randomized, 2X2 Crossover Study to Compare the Pharmacokinetics and Safety Between DWJ1351 and Co-administration of Amlodipine/Olmesartan and Rosuvastatin in Healthy Male Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 04 Dec 2018
Price :
$35
*
At a glance
- Drugs Amlodipine/olmesartan-medoxomil/rosuvastatin (Primary) ; Olmesartan medoxomil/amlodipine; Rosuvastatin
- Indications Hyperlipidaemia; Hypertension
- Focus Pharmacokinetics
- Sponsors Daewoong Pharmaceutical
- 04 Dec 2018 New trial record